BSE filing, NSE: CHOICEIN. Summary written from the filing by ALFA Finder's alert engine.
Choice International Ltd: key numbers
- Share price
- ₹745.00
- Market cap
- ₹16,597 Cr
- Revenue (annual)
- ₹1,119 Cr
- Net profit (annual)
- ₹217.7 Cr
- P/E (TTM)
- 64.8×Sector 19.1×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 9.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choice International Ltd
All →Choice International Earnings Call Transcript: Key Takeaways
Record consolidated revenue of ₹379 Cr (+33%) and PAT of ~₹70 Cr (+23%) at a 34.5% EBITDA margin. Growth was partly IPO-led, and regulatory and NBFC funding-cost risks were acknowledged but not quantified.
Choice International Results Update
Choice International reported record Q2 FY27 consolidated revenue of ₹379 crore, up 33% year-on-year. Net profit rose 23% to ₹69.47 crore.
Choice International Investor Presentation: Key Takeaways
Q2 FY27: Revenue ₹379 Cr (+33% YoY), EBITDA ₹131 Cr (+32%), PAT ₹69.5 Cr (+23%). Diversified broking, advisory, wealth, insurance and NBFC platform; ₹900 Cr NH Investment infusion received.
Choice International Bonus Issue
Choice International approved a 1:1 bonus issue, subject to shareholder approval. It also proposed increasing authorised capital and convening an EGM.
Choice International Q2 FY27 Results: Net Profit ₹69.5 Cr, Up 23.0% YoY
Choice International Ltd reported revenue from operations of ₹372.9 Cr (+35.9% YoY) and net profit of ₹69.5 Cr (+23.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹69.5 Cr · +23.0% YoY
Choice International Board Meeting Date
Choice International will hold a board meeting on 2 November 2026 to approve unaudited results for the quarter and half year ended 30 September 2026. The board will also consider recommending a bonus share issue, subject to shareholder approval.
Other financial results announcements
All →Systematic Industries H1 FY27 Results: Net Profit ₹12.8 Cr, Up 37.6% YoY
Systematic Industries Ltd reported revenue from operations of ₹311.4 Cr (+22.7% YoY) and net profit of ₹12.8 Cr (+37.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹12.8 Cr · +37.6% YoY
Adarsh Plant Protect Q2 FY27 Results: Net Loss of ₹0.2 Cr
Adarsh Plant Protect approved unaudited standalone results for quarter and half-year ended 30 September 2026. Half-year showed a pre-tax loss and lower revenue than last year.
- Key figure
- Net loss ₹0.2 Cr
Nephrocare Health Services Q2 FY27 Results: Turns Profitable, Net Profit ₹33.5 Cr
Nephrocare Health Services Ltd reported revenue from operations of ₹303.4 Cr (+23.5% YoY) and net profit of ₹33.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹33.5 Cr
Sandur Manganese & Iron Ores Q2 FY27 Results: Net Profit ₹261.2 Cr, Up 88.0% YoY
Sandur Manganese & Iron Ores Ltd reported revenue from operations of ₹1,506 Cr (+22.2% YoY) and net profit of ₹261.2 Cr (+88.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹261.2 Cr · +88.0% YoY
Lords Chloro Alkali Q2 FY27 Results: Net Profit ₹9 Cr, Up 0.0% YoY
Lords Chloro Alkali's board approved unaudited results for the quarter and half year ended September 30, 2026. Statutory auditors issued a limited review report on the results.
- Key figure
- Net profit ₹9 Cr · +0.0% YoY
Jenburkt Pharmaceuticals Q2 FY27 Results: Net Profit ₹10.2 Cr, Up 0.0% YoY
Jenburkt Pharmaceuticals posted Q2 revenue of Rs. 4,831.82 lakhs and PAT of Rs. 1,020.94 lakhs. Results were approved on 3 November 2026.
- Key figure
- Net profit ₹10.2 Cr · +0.0% YoY